News
Non-invasive biomarkers and scoring systems show strong capability in differentiating chronic liver disease from cirrhosis, ...
To test their new drug, the researchers conducted experiments on mice that were fed a high-fat diet, which typically leads to ...
Symptoms and Treatment The liver is a vital organ in our body, playing a crucial role in digestion, detoxification, and ...
1h
India Today on MSNFatty liver in pregnancy may increase risk of preterm birthWomen with fatty liver disease while pregnant are at a higher risk of having a preterm birth. (Photo: Getty Images) Pregnant women with a common form of fatty liver disease are more likely to deliver ...
Once-monthly efimosfermin alfa prescribed for metabolic dysfunction–associated steatohepatitis with F2 and F3 fibrosis ...
Distinct trends were seen in etiology-based mortality with chronic liver disease (CLD) before, during, and after the COVID-19 ...
An experimental new treatment is showing early promise in the fight against liver fibrosis—a serious and often silent condition that affects around 2 million people in the UK.
The patient was admitted to the hospital with right flank pain, ongoing fatigue, and general weakness. Diagnostic tests ...
It turns out that in Franklin County, Ohio, over 70% of the deceased in critical categories are male: overdoses (71%), suicides (79%), homicides (79%) and motor vehicle fatalities (74%). This is not ...
17h
MedPage Today on MSNOral IBAT Inhibitor Improves Cholestatic Itch in Primary Biliary CholangitisLinerixibat, an investigational oral ileal bile acid transporter (IBAT) inhibitor, improved cholestatic pruritus in patients ...
21h
PM News on MSNVIDEO: Veteran actor Tito Harrison opens up on liver disease battleSpeaking in an emotional interview on Biola Bayo’s podcast, Harrison disclosed that he was forced to sell his house, cars, ...
The GLISTEN trial of GSK's linerixibat has shown that the oral ileal bile acid transporter (IBAT inhibitor was signposted as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results